New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Washington [US], November 19 (ANI): A study of 1,765 unvaccinated adult American Christians, when presented with an endorsement of the COVID-19 vaccine from a prominent medical expert, participants who were shown cues highlighting the religious identities of the prominent expert and several
Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.
Islamabad [Pakistan], November 11 (ANI): Pakistan on Thursday approved Chinese COVID-19 vaccines Sinopharm and Sinovac for children above 12 with an efficacy rate of 79 per cent and 51 per cent respectively.
Buenos Aires [Argentina], November 1 (ANI/Sputnik): A study conducted by the health ministry of the city of Buenos Aires, Argentina, showed high efficacy of the Russian-made COVID-19 vaccine Sputnik V in protecting people aged 60 and older, the Russian Direct Investment Fund (RDIF) said on M
Washington [US], October 21 (ANI): Pfizer and BioNTech said on Thursday that a booster shot of their COVID-19 vaccine has shown 95.6 per cent efficacy when compared to those who did not receive the booster dose.
Moscow [Russia], October 21 (ANI): Following the decision by the US Food and Drug Administration allowing individuals to receive booster shots that are different from their first COVID-19 vaccine doses, the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) reiterated that
Moscow [Russia], October 13 (ANI): Sputnik Light, Russia's single-dose COVID-19 vaccine, has been found to demonstrate 70 per cent efficacy against infection with the Delta variant during the first three months after vaccination.
Moscow [Russia], September 15 (ANI): The Russian Direct Investment Fund (RDIF) on Wednesday announced the real-world data of Belarus's Health Ministry on the Russian Sputnik V coronavirus vaccine confirming its high efficacy during the vaccination campaign in the country.
Moscow [Russia], September 13 (ANI): The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) has announced the publication of a study in EClinicalMedicine (an open access peer-reviewed clinical journal published by The Lancet, one of the world's most respected medical journ
Beijing [China], September 12 (ANI): South Korean diplomats in Beijing are reluctant to receive Sinopharm or Sinovac COVID-19 vaccines as they doubt the efficacy of the shots.
Washington [US], August 26 (ANI): According to a new West Virginia University study, self-efficacy, optimism, hope and resiliency help inoculate employees from the negative effects of working through a pandemic.